Microencapsulation Of Clomazone By Means Of A Refined Process And Specific Microcapsules Produced Thereof

Patent No. EP2487192 (titled "Microencapsulation Of Clomazone By Means Of A Refined Process And Specific Microcapsules Produced Thereof") was filed by FMC on Mar 30, 2006. The application was issued on Mar 3, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ROTAMDec 2, 2021AKERS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2487192

FMC
Application Number
EP10011557A
Filing Date
Mar 30, 2006
Status
Revoked
Jan 5, 2024
Publication Date
Mar 3, 2021